Primary Record
Aprepitant
- In stock
- 7,788 g
- Purity
- 98.3 %
- CAS
- 170729-80-3
Compound Identifiers & Properties
- CAS
- 170729-80-3
- PubChem CID
- 135413536
- SMILES
- C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
- Canonical SMILES
- C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
Names & Synonyms
- Aprepitant
- Emend
- 170729-80-3
- Cinvanti
- Aponvie
- aprepitantum
- Agrepitant
- Apripetant
- eMende
- MK-869
- Aprepitant [USAN]
- Aprepitant CRS
- Emend (TN)
- Cinvanti (TN)
- aprepitant, form I
- Aponvie (TN)
- MK-0869
- aprepitant, form II
- Aprepitant Impurity I
- Aprepitant (Standard)
- AC1OCFCG
- 1NF15YR6UY
- ONO-7436
- APREPITANT [MI]
- RefChem:57104
- UNII-1NF15YR6UY
- Fosaprepitant Impurity C
- APREPITANT [INN]
- APREPITANT [JAN]
- Aprepitant(MK-0869)
- C23H21F7N4O3
- CHEMBL1471
- APREPITANT [VANDF]
- DTXSID3049047
- D0GU4K
- Aprepitant (MK-0869)
- Aprepitant [USAN:INN:JAN]
- APREPITANT [MART.]
- ATALOFNDEOCMKK-OITMNORJSA-N
- APREPITANT [USP-RS]
- APREPITANT [WHO-DD]
- MFCD08277635
- Aprepitant (JAN/USP/INN)
- Aprepitant Related Compound A
- cc-310
- MLS006011068
- Aprepitant (JAN/USAN/INN)
- APREPITANT [EMA EPAR]
- L-754030
- NSC-748825
- SCHEMBL264924
- SCHEMBL280611
- CHEBI:499361
- MK 869
- Aprepitant - Bio-X trade mark
- DTXCID801021794
- GTPL3490
- orb1307556
- SCHEMBL7117513
- APREPITANT [ORANGE BOOK]
- CTK4D3687
- MK 0869
- A04AD12
- AOB6779
- APREPITANT [EP MONOGRAPH]
- EX-A212
- MK0869
- APREPITANT [USP MONOGRAPH]
- GLXC-05008
- HMS2090N12
- HMS3714E16
- HMS3884G05
- MK869
- ONO 7436
- Tox21_113595
- ABP000600
- BDBM50220136
- EBC-11285
- EBC-27288
- HY-10052R
- MFCD12912491
- MK0517
- NSC748825
- s1189
- ZINC27428713
- AKOS015895498
- AKOS015969344
- Tox21_113595_1
- ACN-037208
- BCP9000312
- C23-H21-F7-N4-O3
- CCG-220747
- CCG-264854
- CID6918365
- CS-0487
- DB00673
- FA17962
- MK-0517
- NSC 748825
- RL02193
- L 754030
- L-754,030
- NCGC00181785-01
- NCGC00181785-03
- NCGC00181785-11
- NCGC00181785-12
- NCGC00344566-01
- AS-14638
- BA164216
- HY-10052
- L982
- SMR002530053
- SY027654
- Aprepitant (MK-0869, L-754030)?
- A3135
- Aprepitant,MK-0869, L-754030, Emend
- CAS-170729-80-3
- FT-0658107
- MK-869, L-754030, Emend, Aprepitant
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- J1.059.639D
- A10083
- A24972
- C21555
- D02968
- EN300-761455
- SBI-0654102.0001
- W-5373
- AB01274775-01
- AB01274775_02
- AB01275535-01
- 729A803
- L754030
- SR-05000001531
- 5-[2(R)-[1(R)-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3(S)-(4-FLUOROPHENYL)MORPHOLIN-4-YLMETHYL]-3,4-DIHYDRO-2H-1,2,4-TRIAZOL-3-ONE
- I06-1151
- L754,030
- SR-05000001531-1
- BRD-K52827117-001-01-6
- L 754,030
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
- Z2937147473
- B2692-461949
- 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one
- 3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one
- 321125-94-4
- 3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-
- 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-3(2H)-one
- 5-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,3-dihydro-1H-1,2,4-triazol-3-one
- Aprepitant, United States Pharmacopeia (USP) Reference Standard
- 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
- 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one
- 3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one
- 3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-
- 5-[(2R,3S)-2-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one
- 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
- (2R)-3alpha-(4-Fluorophenyl)-4-[5(4H)-oxo-1H-1,2,4-triazole-3-ylmethyl]-2alpha-[[(R)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl]oxy]morpholine
- 1148113-53-4
- 221350-96-5
- 3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-4,5-dihydro-1H-1,2,4-triazol-5-one
- 3-(((2R,3S)-3-(P-FLUOROPHENYL)-2-(((.ALPHA.R)-.ALPHA.-METHYL-3,5-BIS(TRIFLUOROMETHYL)BENZYL)OXY)MORPHOLINO)METHYL)-.DELTA.(SUP 2)-1,2,4-TRIAZOLIN-5-ONE.
- 3-[((2R,5-bis(trifluoromethyl)benzyl]oxy}morpholino)methyl]-.delta.2-1,2,4-triazolin-5-one
- 3-[[(2R)-2alpha-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[[(2R)-2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-4,5-dihydro-1H-1,2,4-triazole-5-one
- 3-[[(2R)-2alpha-[[(R)-alpha-Methyl-3,5-di(trifluoromethyl)benzyl]oxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-4,5-dihydro-1H-1,2,4-triazole-5-one
- 3-[[(2R,3S)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[[(2R,3S)-2-[[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl]oxy]-3-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[[(2R,3S)-2-[[(alphaR)-alpha-Methyl-3,5-bis(trifluoromethyl)benzyl]oxy]-3-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[[(2R,3S)-3-(4-Fluorophenyl)-2-[[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]oxy]morpholino]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[[2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[2-{1-[3,5-di(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-1,4-oxazinan-4-ylmethyl]-4,5-dihydro-1H-1,2,4-triazol-5-one
- 3h-1,2,4-triazol-3-ona, 5-[[(2r,3s)-2-[(1r)-1-[3,5-bis(trifluorometil)fenil]etoxi]-3-(4-fluorofenil)-4-morfolinil]metil]-1,2-dihidro-
- 3H-1,2,4-Triazol-3-one, 5-((2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-, (2R-(2alpha(R*),3alpha))-
- 3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, rel-
- 3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,rel-
- 3H-1,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
- 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one
- 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-1,2-dihydro-1,2,4-triazol-3-one
- 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
- 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2H-1,2,4-triazol-3(4H)-one
- 5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol- 3-one
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; Aprepitant; Emend; L 754030; MK 0869; MK 869; ONO 7436; 3H-1,2,4-Triazol-3-one, 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, [2R-[2alpha(R*),3alpha]]-
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-one
- 5-[[(2R,3S)-2-[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-3(2H)-one
- 5-[[2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-2,4-dihydro-3H-1,2,4-triazole-3-one
- 5-[2-[1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one
- 5-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one
- 677-636-6